Zynex reports second quarter 2023 financial results

Q2 2023 revenue increased 22% to $45.0 million; eps $0.09 englewood, colo. , july 27, 2023 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the second quarter ended june 30, 2023.
ZYXI Ratings Summary
ZYXI Quant Ranking